Propel Bio Management, LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 11, 2026, for the 2025 Q4 period, Propel Bio Management, LLC held in its portfolio 20 assets valued at $117,123,993 (i.e. $117.12M).

The most valuable assets in the portfolio included: PLAINS GP HLDGS L P ($24.35M), ACHIEVE LIFE SCIENCES INC ($18.82M), and PHATHOM PHARMACEUTICALS INC ($12.29M).

The chart below shows the top 10 valuable assets, and the table below shows the top 20 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Propel Bio Management, LLC Portfolio

PLAINS GP HLDGS L P

ACHIEVE LIFE SCIENCES INC

PHATHOM PHARMACEUTICALS INC

VIRIDIAN THERAPEUTICS INC

MILESTONE PHARMACEUTICALS

KYVERNA THERAPEUTICS INC

COMPASS PATHWAYS PLC

INVENTIVA SA - ADR

DELCATH SYSTEMS INC

ABEONA THERAPEUTICS INC

Propel Bio Management, LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
PLAINS GP HLDGS L P	1272360	24352970	LTD PARTNR INT A
ACHIEVE LIFE SCIENCES INC	3786425	18818532	COM
PHATHOM PHARMACEUTICALS INC	740918	12291830	COM
VIRIDIAN THERAPEUTICS INC	282531	8792365	COM
MILESTONE PHARMACEUTICALS	4118321	8319008	COM
KYVERNA THERAPEUTICS INC	666666	6266660	COM
COMPASS PATHWAYS PLC	861778	5946268	SPONSORED ADS
INVENTIVA SA - ADR	1000000	4650000	ADS
DELCATH SYSTEMS INC	438509	4428941	COM NEW
ABEONA THERAPEUTICS INC	830780	4378211	COM NEW
CELLDEX THERAPEUTICS INC	154300	4190788	COM NEW
NEKTAR THERAPEUTICS	82822	3501714	COM NEW
OCULIS HOLDING AG	172839	3451595	ORDINARY SHARES
SAB BIOTHERAPEUTICS INC	652881	2441775	COM NEW
REGENXBIO INC	116896	1683302	COM
ATHIRA PHARMA INC	149279	1130042	COM
LENZ THERAPEUTICS INC	59085	945360	COM
AARDVARK THERAPEUTICS INC	46408	609105	COM
ZEVRA THERAPEUTICS INC	63683	570600	COM NEW
KALARIS THERAPEUTICS INC	42053	354927	COM